The Abdala vaccine candidate, one of the four Cuban COVID-19 vaccines currently in clinical trial, is showing favorable results in terms of its safety and immunogenicity, according to the official media. Developed by the Havana Center for Genetic Engineering and Biotechnology (CIGB), the Abdala vaccine candidate was evaluated days ago by an independent committee for … Continue reading Favorable results of Cuban COVID-19 vaccine candidate